Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis
HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or wh...
Saved in:
Published in | Molecular neurobiology Vol. 55; no. 7; pp. 5976 - 5992 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.07.2018
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold (
P
< 0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase (IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1- and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggest that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects. |
---|---|
AbstractList | HIV-1-associated neurocognitive impairment (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold (
P
<0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase(IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1-and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggests that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects. HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold ( P < 0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase (IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1- and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggest that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects. HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold (P < 0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase (IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1- and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggest that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects.HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold (P < 0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase (IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1- and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggest that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects. HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold (P < 0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase (IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1- and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggest that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects. HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors (TLRs) signaling. It is not known whether primary human brain microvascular endothelial cells (HBMEC), the major BBB component, express TLRs or whether TLRs are involved in BBB dysfunction and HAND. We demonstrate that HBMEC express TLR3, 4, 5, 7, 9, and 10, and TLR3 was the most abundant. HIV-1 and TLR3 activation increased endothelial TLR3 transcription and expression. HIV-1-positive human subjects showed significantly higher TLR3 expression in brain tissues and blood vessels, with higher TLR3 levels in subjects with HAND. HIV-1 and TLR3 activation increased endothelial IL6 expression by 6-to-127-fold (P < 0.001), activated c-jun(serine-63) and SAPK/JNK(Thr183/Tyr185). HIV-1 upregulated IL6 through interleukin-1 receptor-associated-kinase (IRAK)-1/4/TAK1/JNK pathways, via ATP-dependent JNK activation. TLR3 activation upregulated IL6 through TAK1/JNK pathways, via ATP-dependent or -independent JNK activation. HIV-1 and TLR3 activation also upregulated transcription factors associated with IL6 and TAK1/JNK pathways (Jun, CEBPA, STAT1). Blocking TLR3 activation prevented HIV-1- and TLR3 ligands-induced upregulation of these transcription factors, prevented IL6 transcription and expression, c-jun and JNK activation. HIV-1 and TLR3 ligands significantly increased monocytes adhesion and migration through the BBB, and decreased endothelial claudin-5 expression. Blocking TLR3 and JNK activation prevented HIV-1- and TLR3 ligands-induced claudin-5 downregulation, monocytes adhesion and transendothelial migration. These data suggest that viral immune recognition via endothelial TLR3 is involved in endothelial inflammation and BBB dysfunction in HIV/AIDS and HAND. Our data provides novel insights into the molecular basis of these HIV-1- and TLR3-mediated effects. |
Author | Bhargavan, Biju Kanmogne, Georgette D. |
Author_xml | – sequence: 1 givenname: Biju surname: Bhargavan fullname: Bhargavan, Biju organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center – sequence: 2 givenname: Georgette D. orcidid: 0000-0001-8564-3643 surname: Kanmogne fullname: Kanmogne, Georgette D. email: gkanmogne@unmc.edu organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29128906$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstuEzEYhUeoiF7gAdggS2zYGHyZjD0skEoVSGgoCIVuLY_9J3E7Yw_2TKFPxGvikJZLJVhZtr9zdH77HBZ7PngoiseUPKeEiBeJMsInmFCBiaQVlveKAzqZ1JhSyfaKAyJrjkVVyv3iMKULQhijRDwo9llNmaxJdVB8X4a2xQt3CegTGOiHEDFH78E6PUBCs_k5pnju7WjAorkfILYwXjqPKzT91kdIyQWPnEfDBtBs7LRHr6PO-6m3IZ-1buzQldNoeXxKkfYWvTs7RR_1sPmqr9NLNO_61hk9ZJeEViGicxd1i85gjKHPVFiDh-TSw-L-SrcJHt2sR8XnN9PlyQwvPrydnxwvsClrPmALdFWXDZeMEwHc2oZpWdLGWAG2bERtbEOlthU33HINzBq74rw2K2KkkA0_Kl7tfPux6cAa8EPOo_roOh2vVdBO_X3j3Uatw5WqGKuYkNng2Y1BDF9GSIPqXDLQttpDGJOidcVLMSkJz-jTO-hFGKPP4ylGJkxKLmSZqSd_JvoV5fYPMyB2gIkhpQgrZdzw80VzQNcqStS2LWrXFpXborZtUdus9I7y1vx_GrbTpMz6NcTfof8t-gHSlNO- |
CitedBy_id | crossref_primary_10_3389_fphys_2019_00306 crossref_primary_10_1038_s41598_019_47069_9 crossref_primary_10_1186_s12977_021_00569_x crossref_primary_10_1080_21688370_2020_1860616 crossref_primary_10_1016_j_heliyon_2023_e21307 crossref_primary_10_1016_j_jneuroim_2019_577047 crossref_primary_10_1128_mBio_02817_21 crossref_primary_10_1016_j_molmed_2021_10_007 crossref_primary_10_1016_j_ejphar_2024_176842 crossref_primary_10_3390_ijms241612585 crossref_primary_10_1007_s10157_018_1659_y crossref_primary_10_1007_s10753_022_01664_7 crossref_primary_10_1016_j_ddmod_2019_10_007 crossref_primary_10_1146_annurev_immunol_042718_041417 crossref_primary_10_3390_genes15101351 crossref_primary_10_3390_microorganisms8111787 crossref_primary_10_3390_ijms21176148 crossref_primary_10_1016_j_expneurol_2018_07_016 crossref_primary_10_1007_s12035_021_02319_8 crossref_primary_10_1159_000506482 crossref_primary_10_3390_ijms231810436 crossref_primary_10_1007_s11684_021_0831_z |
Cites_doi | 10.1038/jcbfm.2014.54 10.1016/j.immuni.2010.03.012 10.1371/journal.pone.0160875 10.1016/j.it.2012.03.001 10.1161/CIRCRESAHA.111.243246 10.1074/jbc.M310175200 10.1093/ndt/gfp339 10.1073/pnas.0603245103 10.4049/jimmunol.176.3.1348 10.1016/j.nbd.2003.12.016 10.2174/157016206777709447 10.4049/jimmunol.175.8.5314 10.1016/S1357-2725(97)00063-0 10.1038/sj.jcbfm.9600330 10.4049/jimmunol.180.5.3399 10.1002/j.1460-2075.1996.tb00636.x 10.1097/QAI.0000000000000915 10.1007/s10571-004-1383-x 10.1097/QAD.0000000000000155 10.1172/JCI0215536 10.1089/aid.2013.0199 10.1073/pnas.0710779105 10.1182/blood-2008-07-019307 10.1016/j.cellsig.2015.11.005 10.1016/j.str.2011.02.004 10.1038/35099560 10.1038/sj.jcbfm.9600567 10.1196/annals.1443.020 10.1016/S0092-8674(05)80019-4 10.4049/jimmunol.170.6.3099 10.1159/000218082 10.1016/j.bbrc.2009.08.062 10.2741/1427 10.1128/CMR.00022-07 10.1016/j.intimp.2011.05.006 10.1016/j.smim.2014.01.009 10.1128/JVI.80.10.5059-5064.2006 10.1097/QAD.0b013e3282f4de35 10.1371/journal.pone.0025837 10.4049/jimmunol.175.7.4320 10.1158/1078-0432.CCR-14-2291 10.1038/nm1140 10.1016/j.mvr.2008.11.003 10.1038/sj.onc.1204239 10.1016/S0092-8674(00)81999-6 10.1016/0952-7915(93)90091-6 10.1111/j.1365-2567.2007.02799.x 10.1007/s11481-006-9025-3 10.1016/j.exer.2015.06.012 10.1016/j.neuint.2010.07.002 10.3851/IMP2093 10.1016/j.intimp.2011.04.025 10.1007/s12035-017-0382-0 10.1101/cshperspect.a016295 10.1002/rmv.680 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC 2017 Molecular Neurobiology is a copyright of Springer, (2017). All Rights Reserved. |
Copyright_xml | – notice: Springer Science+Business Media, LLC 2017 – notice: Molecular Neurobiology is a copyright of Springer, (2017). All Rights Reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QR 7TK 7X7 7XB 88A 88E 88G 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M2P M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1007/s12035-017-0816-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Chemoreception Abstracts Neurosciences Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Proquest Medical Database Psychology Database Science Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1559-1182 |
EndPage | 5992 |
ExternalDocumentID | PMC6226278 29128906 10_1007_s12035_017_0816_8 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Institute of Mental Health grantid: R01 MH094160 funderid: http://dx.doi.org/10.13039/100000025 – fundername: NIMH NIH HHS grantid: R01 MH094160 – fundername: National Institute of Mental Health grantid: R01 MH094160 |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C -~X .86 .GJ .VR 06C 06D 0R~ 0VY 123 1N0 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 3V. 4.4 406 408 40D 40E 53G 5VS 67N 6NX 78A 7X7 88A 88E 88I 8AO 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACGOD ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AIAKS AIGIU AIIXL AILAN AITGF AIZAD AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP D1J DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 H13 HCIFZ HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR IXC I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV LK8 LLZTM M0L M1P M2M M2P M4Y M7P MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 XJT YLTOR Z7U Z7W Z82 Z83 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHDLI AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c493t-de1f94b382307e3ddb2a841bcd7ed4b79cdb18ad63c3d3ae2dcdf339cf0c878b3 |
IEDL.DBID | U2A |
ISSN | 0893-7648 1559-1182 |
IngestDate | Thu Aug 21 14:25:47 EDT 2025 Fri Jul 11 11:50:19 EDT 2025 Fri Jul 25 09:24:24 EDT 2025 Mon Jul 21 05:58:11 EDT 2025 Tue Jul 01 01:04:41 EDT 2025 Thu Apr 24 23:08:29 EDT 2025 Fri Feb 21 02:38:15 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | HIV-1 IL6 Monocytes Blood-brain barrier Claudin-5 TAK1/MKK7/JNK signaling Human brain microvascular endothelial cells TLR3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c493t-de1f94b382307e3ddb2a841bcd7ed4b79cdb18ad63c3d3ae2dcdf339cf0c878b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-8564-3643 |
PMID | 29128906 |
PQID | 2052883784 |
PQPubID | 55365 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6226278 proquest_miscellaneous_1963475403 proquest_journals_2052883784 pubmed_primary_29128906 crossref_citationtrail_10_1007_s12035_017_0816_8 crossref_primary_10_1007_s12035_017_0816_8 springer_journals_10_1007_s12035_017_0816_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-07-01 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Totowa |
PublicationTitle | Molecular neurobiology |
PublicationTitleAbbrev | Mol Neurobiol |
PublicationTitleAlternate | Mol Neurobiol |
PublicationYear | 2018 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Wang, Smith, Bot, Dellamary, Bloom, Bot (CR7) 2002; 110 Berger, Avison (CR22) 2004; 9 Blasius, Beutler (CR4) 2010; 32 Bell, Askins, Hall, Davies, Segal (CR48) 2006; 103 Hagele, Allam, Pawar, Anders (CR44) 2009; 24 Karikó, Ni, Capodici, Lamphier, Weissman (CR8) 2004; 279 Hamlyn, Fidler, Stohr, Cooper, Tambussi, Schechter, Miro, McClure, Weber, Babiker (CR42) 2014; 28 Bhargavan, Woollard, Kanmogne (CR19) 2016; 28 Beutler (CR2) 2009; 113 Chaudhuri, Yang, Gendelman, Persidsky, Kanmogne (CR26) 2008; 2062-2072 Jack, Arbour, Manusow, Montgrain, Blain, McCrea, Shapiro, Antel (CR5) 2005; 175 Persidsky, Ramirez, Haorah, Kanmogne (CR21) 2006; 1 Scagnolari, Selvaggi, Chiavuzzo, Carbone, Zaffiri, d'Ettorre, Girardi, Turriziani, Vullo, Antonelli (CR39) 2009; 52 van Dam, Castellazzi (CR54) 2001; 20 Botos, Segal, Davies (CR3) 2011; 19 Buitendijk, Eszterhas, Howell (CR18) 2014; 30 Chaudhuri, Duan, Morsey, Persidsky, Kanmogne (CR25) 2008; 28 Weber, Wagner, Rasmussen, Hartmann, Paludan (CR37) 2006; 80 Alexopoulou, Holt, Medzhitov, Flavell (CR6) 2001; 413 Zimmer, Steinmetz, Asdonk, Motz, Coch, Hartmann, Barchet, Wassmann, Hartmann, Nickenig (CR46) 2011; 108 Nagyoszi, Wilhelm, Farkas, Fazakas, Dung, Hasko, Krizbai (CR34) 2010; 57 Ballabh, Braun, Nedergaard (CR20) 2004; 16 Baccam, Woo, Vinson, Bishop (CR33) 2003; 170 Kim, Yang, Lee, Kim, Shin, Park, Choi, Kim, Choi (CR17) 2008; 124 Kumar, Kawai, Akira (CR1) 2009; 388 Huang, Stuart, Takeda, D'Agnillo, Golding (CR45) 2016; 11 Pegu, Qin, Fallert Junecko, Nisato, Pepper, Reinhart (CR35) 2008; 180 Wang, Town, Alexopoulou, Anderson, Fikrig, Flavell (CR10) 2004; 10 Chen-Kiang, Hsu, Natkunam, Zhang (CR31) 1993; 5 Rossi, Lu, Jourdan, Klein (CR57) 2015; 21 Woollard, Bhargavan, Yu, Kanmogne (CR27) 2014; 34 Toborek, Lee, Flora, Pu, Andras, Wylegala, Hennig, Nath (CR23) 2005; 25 Kawai, Akira (CR38) 2008; 1143 Hanamsagar, Hanke, Kielian (CR13) 2012; 33 Minden, Lin, Claret, Abo, Karin (CR53) 1995; 81 CR12 Vercammen, Staal, Beyaert (CR11) 2008; 21 Gupta, Barrett, Whitmarsh, Cavanagh, Sluss, Derijard, Davis (CR51) 1996; 15 CR55 Kanmogne, Schall, Leibhart, Knipe, Gendelman, Persidsky (CR30) 2007; 27 Akira (CR32) 1997; 29 Leonard, Ghirlando, Askins, Bell, Margulies, Davies, Segal (CR47) 2008; 105 Lester, Yao, Ball, McKinnon, Kaul, Wachihi, Jaoko, Plummer, Rosenthal (CR40) 2008; 22 Yang, Akhter, Chaudhuri, Kanmogne (CR29) 2009; 77 Minden, Karin (CR52) 1997; 1333 Bastard, Soulie, Fellahi, Haim-Boukobza, Simon, Katlama, Calvez, Marcelin, Capeau (CR41) 2012; 17 Lai, Yi, Chen, Bhardwaj, Tragesser, Rodrigo, Zlotnick, Mukhopadhyay, Ranjith-Kumar, Kao (CR49) 2011; 6 Arroyo, Soria, Gaviglio, Rodriguez-Galan, Iribarren (CR15) 2011; 11 Wesch, Beetz, Oberg, Marget, Krengel, Kabelitz (CR9) 2006; 176 CR28 Kallunki, Deng, Hibi, Karin (CR50) 1996; 87 Tanaka, Narazaki, Ogata, Kishimoto (CR56) 2014; 26 Olwenyi, Naluyima, Cham, Quinn, Serwadda, Sewankambo, Gray, Sandberg, Michael, Wabwire-Mangen (CR43) 2016; 72 Banks, Ercal, Price (CR24) 2006; 4 Kong, Le (CR14) 2011; 11 Stewart, Wei, Branch, Sidney, Amoaku (CR36) 2015; 138 Sanghavi, Reinhart (CR16) 2005; 175 M Baccam (816_CR33) 2003; 170 E Vercammen (816_CR11) 2008; 21 T Wang (816_CR10) 2004; 10 GD Kanmogne (816_CR30) 2007; 27 SK Sanghavi (816_CR16) 2005; 175 JN Leonard (816_CR47) 2008; 105 EA Stewart (816_CR36) 2015; 138 H van Dam (816_CR54) 2001; 20 B Bhargavan (816_CR19) 2016; 28 P Nagyoszi (816_CR34) 2010; 57 E Hamlyn (816_CR42) 2014; 28 L Wang (816_CR7) 2002; 110 BA Beutler (816_CR2) 2009; 113 P Ballabh (816_CR20) 2004; 16 S Zimmer (816_CR46) 2011; 108 816_CR12 H Kim (816_CR17) 2008; 124 LY Huang (816_CR45) 2016; 11 816_CR55 AL Blasius (816_CR4) 2010; 32 H Kumar (816_CR1) 2009; 388 A Chaudhuri (816_CR25) 2008; 28 DS Arroyo (816_CR15) 2011; 11 T Kallunki (816_CR50) 1996; 87 JR Berger (816_CR22) 2004; 9 T Kawai (816_CR38) 2008; 1143 L Alexopoulou (816_CR6) 2001; 413 B Yang (816_CR29) 2009; 77 816_CR28 I Botos (816_CR3) 2011; 19 A Minden (816_CR52) 1997; 1333 K Karikó (816_CR8) 2004; 279 M Toborek (816_CR23) 2005; 25 RT Lester (816_CR40) 2008; 22 J-F Rossi (816_CR57) 2015; 21 D Wesch (816_CR9) 2006; 176 R Hanamsagar (816_CR13) 2012; 33 Y Kong (816_CR14) 2011; 11 C Scagnolari (816_CR39) 2009; 52 S Chen-Kiang (816_CR31) 1993; 5 Y Lai (816_CR49) 2011; 6 A Minden (816_CR53) 1995; 81 S Gupta (816_CR51) 1996; 15 Y Persidsky (816_CR21) 2006; 1 WA Banks (816_CR24) 2006; 4 CS Jack (816_CR5) 2005; 175 T Tanaka (816_CR56) 2014; 26 JK Bell (816_CR48) 2006; 103 SM Woollard (816_CR27) 2014; 34 F Weber (816_CR37) 2006; 80 S Akira (816_CR32) 1997; 29 H Hagele (816_CR44) 2009; 24 A Pegu (816_CR35) 2008; 180 OA Olwenyi (816_CR43) 2016; 72 M Buitendijk (816_CR18) 2014; 30 JP Bastard (816_CR41) 2012; 17 A Chaudhuri (816_CR26) 2008; 2062-2072 |
References_xml | – volume: 34 start-page: 1047 year: 2014 end-page: 1059 ident: CR27 article-title: Differential effects of tat proteins derived from hiv-1 subtypes b and recombinant crf02_ag on human brain microvascular endothelial cells: Implications for blood-brain barrier dysfunction publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.2014.54 – volume: 32 start-page: 305 year: 2010 end-page: 315 ident: CR4 article-title: Intracellular toll-like receptors publication-title: Immunity doi: 10.1016/j.immuni.2010.03.012 – volume: 11 start-page: e0160875 year: 2016 ident: CR45 article-title: Poly(i:C) induces human lung endothelial barrier dysfunction by disrupting tight junction expression of claudin-5 publication-title: PLoS One doi: 10.1371/journal.pone.0160875 – ident: CR12 – volume: 33 start-page: 333 year: 2012 end-page: 342 ident: CR13 article-title: Toll-like receptor (tlr) and inflammasome actions in the central nervous system publication-title: Trends Immunol doi: 10.1016/j.it.2012.03.001 – volume: 108 start-page: 1358 year: 2011 end-page: 1366 ident: CR46 article-title: Activation of endothelial toll-like receptor 3 impairs endothelial function publication-title: Circ Res doi: 10.1161/CIRCRESAHA.111.243246 – volume: 279 start-page: 12542 year: 2004 end-page: 12550 ident: CR8 article-title: MRNA is an endogenous ligand for toll-like receptor 3 publication-title: J Biol Chem doi: 10.1074/jbc.M310175200 – volume: 24 start-page: 3312 year: 2009 end-page: 3318 ident: CR44 article-title: Double-stranded rna activates type i interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (rig)-1 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfp339 – volume: 103 start-page: 8792 year: 2006 end-page: 8797 ident: CR48 article-title: The dsrna binding site of human toll-like receptor 3 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0603245103 – volume: 176 start-page: 1348 year: 2006 end-page: 1354 ident: CR9 article-title: Direct costimulatory effect of tlr3 ligand poly(i:C) on human γδ t lymphocytes publication-title: J Immunol doi: 10.4049/jimmunol.176.3.1348 – volume: 16 start-page: 1 year: 2004 end-page: 13 ident: CR20 article-title: The blood-brain barrier: an overview: structure, regulation, and clinical implications publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2003.12.016 – volume: 4 start-page: 259 year: 2006 end-page: 266 ident: CR24 article-title: The blood-brain barrier in neuroaids publication-title: Curr HIV Res doi: 10.2174/157016206777709447 – volume: 175 start-page: 5314 year: 2005 end-page: 5323 ident: CR16 article-title: Increased expression of tlr3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency publication-title: J Immunol doi: 10.4049/jimmunol.175.8.5314 – volume: 29 start-page: 1401 year: 1997 end-page: 1418 ident: CR32 article-title: Il-6-regulated transcription factors publication-title: Int J Biochem Cell Biol doi: 10.1016/S1357-2725(97)00063-0 – volume: 27 start-page: 123 year: 2007 end-page: 134 ident: CR30 article-title: Hiv-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis publication-title: J Cereb Blood Flow Metab doi: 10.1038/sj.jcbfm.9600330 – volume: 1333 start-page: F85 year: 1997 end-page: 104 ident: CR52 article-title: Regulation and function of the jnk subgroup of map kinases publication-title: Biochim Biophys Acta – volume: 180 start-page: 3399 year: 2008 end-page: 3405 ident: CR35 article-title: Human lymphatic endothelial cells express multiple functional tlrs publication-title: J Immunol doi: 10.4049/jimmunol.180.5.3399 – volume: 15 start-page: 2760 year: 1996 end-page: 2770 ident: CR51 article-title: Selective interaction of jnk protein kinase isoforms with transcription factors publication-title: EMBO J doi: 10.1002/j.1460-2075.1996.tb00636.x – volume: 72 start-page: 15 year: 2016 end-page: 20 ident: CR43 article-title: Brief report: differential associations of interleukin 6 and intestinal fatty acid-binding protein with progressive untreated hiv-1 infection in Rakai, Uganda publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000915 – volume: 25 start-page: 181 year: 2005 end-page: 199 ident: CR23 article-title: Mechanisms of the blood-brain barrier disruption in HIV-1 infection publication-title: Cell Mol Neurobiol doi: 10.1007/s10571-004-1383-x – volume: 28 start-page: 869 year: 2014 end-page: 874 ident: CR42 article-title: Interleukin-6 and d-dimer levels at seroconversion as predictors of hiv-1 disease progression publication-title: AIDS doi: 10.1097/QAD.0000000000000155 – volume: 110 start-page: 1175 year: 2002 end-page: 1184 ident: CR7 article-title: Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination publication-title: J Clin Invest doi: 10.1172/JCI0215536 – volume: 30 start-page: 457 year: 2014 end-page: 467 ident: CR18 article-title: Toll-like receptor agonists are potent inhibitors of human immunodeficiency virus-type 1 replication in peripheral blood mononuclear cells publication-title: AIDS Res Hum Retrovir doi: 10.1089/aid.2013.0199 – volume: 105 start-page: 258 year: 2008 end-page: 263 ident: CR47 article-title: The tlr3 signaling complex forms by cooperative receptor dimerization publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0710779105 – volume: 113 start-page: 1399 year: 2009 end-page: 1407 ident: CR2 article-title: TLRs and innate immunity publication-title: Blood doi: 10.1182/blood-2008-07-019307 – volume: 28 start-page: 7 year: 2016 end-page: 22 ident: CR19 article-title: Toll-like receptor-3 mediates hiv-1 transactivation via nfκb and jnk pathways and histone acetylation, but prolonged activation suppresses tat and hiv-1 replication publication-title: Cell Signal doi: 10.1016/j.cellsig.2015.11.005 – volume: 19 start-page: 447 year: 2011 end-page: 459 ident: CR3 article-title: The structural biology of toll-like receptors publication-title: Structure doi: 10.1016/j.str.2011.02.004 – volume: 413 start-page: 732 year: 2001 end-page: 738 ident: CR6 article-title: Recognition of double-stranded RNA and activation of NF-[kappa]b by toll-like receptor 3 publication-title: Nature doi: 10.1038/35099560 – volume: 28 start-page: 697 year: 2008 end-page: 711 ident: CR25 article-title: Hiv-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction publication-title: J Cereb Blood Flow Metab doi: 10.1038/sj.jcbfm.9600567 – volume: 1143 start-page: 1 year: 2008 end-page: 20 ident: CR38 article-title: Toll-like receptor and rig-i-like receptor signaling publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1443.020 – volume: 81 start-page: 1147 year: 1995 end-page: 1157 ident: CR53 article-title: Selective activation of the jnk signaling cascade and c-jun transcriptional activity by the small gtpases rac and cdc42hs publication-title: Cell doi: 10.1016/S0092-8674(05)80019-4 – volume: 170 start-page: 3099 year: 2003 end-page: 3108 ident: CR33 article-title: Cd40-mediated transcriptional regulation of the il-6 gene in b lymphocytes: involvement of nf-kappa b, ap-1, and c/ebp publication-title: J Immunol doi: 10.4049/jimmunol.170.6.3099 – volume: 52 start-page: 107 year: 2009 end-page: 114 ident: CR39 article-title: Expression levels of tlrs involved in viral recognition in pbmcs from hiv-1-infected patients failing antiretroviral therapy publication-title: Intervirology doi: 10.1159/000218082 – volume: 388 start-page: 621 year: 2009 end-page: 625 ident: CR1 article-title: Toll-like receptors and innate immunity publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.08.062 – volume: 9 start-page: 2680 year: 2004 end-page: 2685 ident: CR22 article-title: The blood brain barrier in HIV infection publication-title: Front Biosci doi: 10.2741/1427 – volume: 21 start-page: 13 year: 2008 end-page: 25 ident: CR11 article-title: Sensing of viral infection and activation of innate immunity by toll-like receptor 3 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00022-07 – volume: 11 start-page: 1415 year: 2011 end-page: 1421 ident: CR15 article-title: Toll-like receptors are key players in neurodegeneration publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2011.05.006 – volume: 26 start-page: 88 year: 2014 end-page: 96 ident: CR56 article-title: A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy publication-title: Semin Immunol doi: 10.1016/j.smim.2014.01.009 – volume: 80 start-page: 5059 year: 2006 end-page: 5064 ident: CR37 article-title: Double-stranded rna is produced by positive-strand rna viruses and DNA viruses but not in detectable amounts by negative-strand rna viruses publication-title: J Virol doi: 10.1128/JVI.80.10.5059-5064.2006 – volume: 22 start-page: 685 year: 2008 end-page: 694 ident: CR40 article-title: Toll-like receptor expression and responsiveness are increased in viraemic hiv-1 infection publication-title: AIDS doi: 10.1097/QAD.0b013e3282f4de35 – volume: 6 start-page: e25837 year: 2011 ident: CR49 article-title: Viral double-strand rna-binding proteins can enhance innate immune signaling by toll-like receptor 3 publication-title: PLoS One doi: 10.1371/journal.pone.0025837 – volume: 175 start-page: 4320 year: 2005 end-page: 4330 ident: CR5 article-title: TLR signaling tailors innate immune responses in human microglia and astrocytes publication-title: J Immunol doi: 10.4049/jimmunol.175.7.4320 – volume: 21 start-page: 1248 year: 2015 end-page: 1257 ident: CR57 article-title: Interleukin-6 as a therapeutic target publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-2291 – volume: 2062-2072 start-page: 111 year: 2008 ident: CR26 article-title: Stat1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier publication-title: Blood – volume: 10 start-page: 1366 year: 2004 end-page: 1373 ident: CR10 article-title: Toll-like receptor 3 mediates west nile virus entry into the brain causing lethal encephalitis publication-title: Nat Med doi: 10.1038/nm1140 – volume: 77 start-page: 212 year: 2009 end-page: 219 ident: CR29 article-title: Hiv-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of stat1 signaling publication-title: Microvasc Res doi: 10.1016/j.mvr.2008.11.003 – volume: 20 start-page: 2453 year: 2001 end-page: 2464 ident: CR54 article-title: Distinct roles of jun: Fos and jun: Atf dimers in oncogenesis publication-title: Oncogene doi: 10.1038/sj.onc.1204239 – volume: 87 start-page: 929 year: 1996 end-page: 939 ident: CR50 article-title: C-jun can recruit jnk to phosphorylate dimerization partners via specific docking interactions publication-title: Cell doi: 10.1016/S0092-8674(00)81999-6 – volume: 5 start-page: 124 year: 1993 end-page: 128 ident: CR31 article-title: Nuclear signaling by interleukin-6 publication-title: Curr Opin Immunol doi: 10.1016/0952-7915(93)90091-6 – volume: 124 start-page: 480 year: 2008 end-page: 488 ident: CR17 article-title: Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging toll-like receptor 3 in human brain astrocytes publication-title: Immunology doi: 10.1111/j.1365-2567.2007.02799.x – volume: 1 start-page: 223 year: 2006 end-page: 236 ident: CR21 article-title: Blood-brain barrier: Structural components and function under physiologic and pathologic conditions publication-title: J NeuroImmune Pharmacol doi: 10.1007/s11481-006-9025-3 – volume: 138 start-page: 114 year: 2015 end-page: 123 ident: CR36 article-title: Expression of toll-like receptors in human retinal and choroidal vascular endothelial cells publication-title: Exp Eye Res doi: 10.1016/j.exer.2015.06.012 – volume: 57 start-page: 556 year: 2010 end-page: 564 ident: CR34 article-title: Expression and regulation of toll-like receptors in cerebral endothelial cells publication-title: Neurochem Int doi: 10.1016/j.neuint.2010.07.002 – ident: CR55 – volume: 17 start-page: 915 year: 2012 end-page: 919 ident: CR41 article-title: Circulating interleukin-6 levels correlate with residual hiv viraemia and markers of immune dysfunction in treatment-controlled hiv-infected patients publication-title: Antivir Ther doi: 10.3851/IMP2093 – volume: 11 start-page: 1407 year: 2011 end-page: 1414 ident: CR14 article-title: Toll-like receptors in inflammation of the central nervous system publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2011.04.025 – ident: CR28 – volume: 1333 start-page: F85 year: 1997 ident: 816_CR52 publication-title: Biochim Biophys Acta – volume: 22 start-page: 685 year: 2008 ident: 816_CR40 publication-title: AIDS doi: 10.1097/QAD.0b013e3282f4de35 – volume: 21 start-page: 1248 year: 2015 ident: 816_CR57 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-2291 – volume: 113 start-page: 1399 year: 2009 ident: 816_CR2 publication-title: Blood doi: 10.1182/blood-2008-07-019307 – volume: 15 start-page: 2760 year: 1996 ident: 816_CR51 publication-title: EMBO J doi: 10.1002/j.1460-2075.1996.tb00636.x – volume: 170 start-page: 3099 year: 2003 ident: 816_CR33 publication-title: J Immunol doi: 10.4049/jimmunol.170.6.3099 – volume: 34 start-page: 1047 year: 2014 ident: 816_CR27 publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.2014.54 – volume: 103 start-page: 8792 year: 2006 ident: 816_CR48 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0603245103 – volume: 6 start-page: e25837 year: 2011 ident: 816_CR49 publication-title: PLoS One doi: 10.1371/journal.pone.0025837 – volume: 72 start-page: 15 year: 2016 ident: 816_CR43 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000915 – volume: 33 start-page: 333 year: 2012 ident: 816_CR13 publication-title: Trends Immunol doi: 10.1016/j.it.2012.03.001 – volume: 279 start-page: 12542 year: 2004 ident: 816_CR8 publication-title: J Biol Chem doi: 10.1074/jbc.M310175200 – volume: 11 start-page: 1407 year: 2011 ident: 816_CR14 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2011.04.025 – volume: 110 start-page: 1175 year: 2002 ident: 816_CR7 publication-title: J Clin Invest doi: 10.1172/JCI0215536 – volume: 28 start-page: 7 year: 2016 ident: 816_CR19 publication-title: Cell Signal doi: 10.1016/j.cellsig.2015.11.005 – volume: 108 start-page: 1358 year: 2011 ident: 816_CR46 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.111.243246 – volume: 10 start-page: 1366 year: 2004 ident: 816_CR10 publication-title: Nat Med doi: 10.1038/nm1140 – volume: 124 start-page: 480 year: 2008 ident: 816_CR17 publication-title: Immunology doi: 10.1111/j.1365-2567.2007.02799.x – volume: 77 start-page: 212 year: 2009 ident: 816_CR29 publication-title: Microvasc Res doi: 10.1016/j.mvr.2008.11.003 – volume: 87 start-page: 929 year: 1996 ident: 816_CR50 publication-title: Cell doi: 10.1016/S0092-8674(00)81999-6 – volume: 32 start-page: 305 year: 2010 ident: 816_CR4 publication-title: Immunity doi: 10.1016/j.immuni.2010.03.012 – volume: 80 start-page: 5059 year: 2006 ident: 816_CR37 publication-title: J Virol doi: 10.1128/JVI.80.10.5059-5064.2006 – volume: 11 start-page: e0160875 year: 2016 ident: 816_CR45 publication-title: PLoS One doi: 10.1371/journal.pone.0160875 – volume: 388 start-page: 621 year: 2009 ident: 816_CR1 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.08.062 – volume: 28 start-page: 869 year: 2014 ident: 816_CR42 publication-title: AIDS doi: 10.1097/QAD.0000000000000155 – ident: 816_CR28 doi: 10.1007/s12035-017-0382-0 – volume: 4 start-page: 259 year: 2006 ident: 816_CR24 publication-title: Curr HIV Res doi: 10.2174/157016206777709447 – volume: 26 start-page: 88 year: 2014 ident: 816_CR56 publication-title: Semin Immunol doi: 10.1016/j.smim.2014.01.009 – volume: 413 start-page: 732 year: 2001 ident: 816_CR6 publication-title: Nature doi: 10.1038/35099560 – ident: 816_CR55 doi: 10.1101/cshperspect.a016295 – volume: 9 start-page: 2680 year: 2004 ident: 816_CR22 publication-title: Front Biosci doi: 10.2741/1427 – volume: 24 start-page: 3312 year: 2009 ident: 816_CR44 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfp339 – volume: 180 start-page: 3399 year: 2008 ident: 816_CR35 publication-title: J Immunol doi: 10.4049/jimmunol.180.5.3399 – volume: 176 start-page: 1348 year: 2006 ident: 816_CR9 publication-title: J Immunol doi: 10.4049/jimmunol.176.3.1348 – volume: 57 start-page: 556 year: 2010 ident: 816_CR34 publication-title: Neurochem Int doi: 10.1016/j.neuint.2010.07.002 – volume: 105 start-page: 258 year: 2008 ident: 816_CR47 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0710779105 – volume: 11 start-page: 1415 year: 2011 ident: 816_CR15 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2011.05.006 – volume: 19 start-page: 447 year: 2011 ident: 816_CR3 publication-title: Structure doi: 10.1016/j.str.2011.02.004 – ident: 816_CR12 doi: 10.1002/rmv.680 – volume: 81 start-page: 1147 year: 1995 ident: 816_CR53 publication-title: Cell doi: 10.1016/S0092-8674(05)80019-4 – volume: 2062-2072 start-page: 111 year: 2008 ident: 816_CR26 publication-title: Blood – volume: 175 start-page: 4320 year: 2005 ident: 816_CR5 publication-title: J Immunol doi: 10.4049/jimmunol.175.7.4320 – volume: 175 start-page: 5314 year: 2005 ident: 816_CR16 publication-title: J Immunol doi: 10.4049/jimmunol.175.8.5314 – volume: 27 start-page: 123 year: 2007 ident: 816_CR30 publication-title: J Cereb Blood Flow Metab doi: 10.1038/sj.jcbfm.9600330 – volume: 30 start-page: 457 year: 2014 ident: 816_CR18 publication-title: AIDS Res Hum Retrovir doi: 10.1089/aid.2013.0199 – volume: 17 start-page: 915 year: 2012 ident: 816_CR41 publication-title: Antivir Ther doi: 10.3851/IMP2093 – volume: 29 start-page: 1401 year: 1997 ident: 816_CR32 publication-title: Int J Biochem Cell Biol doi: 10.1016/S1357-2725(97)00063-0 – volume: 1143 start-page: 1 year: 2008 ident: 816_CR38 publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1443.020 – volume: 28 start-page: 697 year: 2008 ident: 816_CR25 publication-title: J Cereb Blood Flow Metab doi: 10.1038/sj.jcbfm.9600567 – volume: 21 start-page: 13 year: 2008 ident: 816_CR11 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00022-07 – volume: 138 start-page: 114 year: 2015 ident: 816_CR36 publication-title: Exp Eye Res doi: 10.1016/j.exer.2015.06.012 – volume: 25 start-page: 181 year: 2005 ident: 816_CR23 publication-title: Cell Mol Neurobiol doi: 10.1007/s10571-004-1383-x – volume: 5 start-page: 124 year: 1993 ident: 816_CR31 publication-title: Curr Opin Immunol doi: 10.1016/0952-7915(93)90091-6 – volume: 52 start-page: 107 year: 2009 ident: 816_CR39 publication-title: Intervirology doi: 10.1159/000218082 – volume: 16 start-page: 1 year: 2004 ident: 816_CR20 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2003.12.016 – volume: 20 start-page: 2453 year: 2001 ident: 816_CR54 publication-title: Oncogene doi: 10.1038/sj.onc.1204239 – volume: 1 start-page: 223 year: 2006 ident: 816_CR21 publication-title: J NeuroImmune Pharmacol doi: 10.1007/s11481-006-9025-3 |
SSID | ssj0022107 |
Score | 2.3421602 |
Snippet | HIV-1-associated neurocognitive disorders (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors... HIV-1-associated neurocognitive impairment (HAND) is associated with blood-brain-barrier (BBB) inflammation, and inflammation involves toll-like receptors... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5976 |
SubjectTerms | Acquired immune deficiency syndrome Adult Aged AIDS Biomedical and Life Sciences Biomedicine Blood vessels Blood-brain barrier Brain Brain - pathology c-Jun protein Cell activation Cell Biology Cognition Cytokines Endothelial cells Endothelial Cells - metabolism Endothelial Cells - pathology Endothelial Cells - virology Endothelium Female HIV HIV Infections - genetics HIV Infections - pathology HIV-1 - physiology Human immunodeficiency virus Humans Inflammation Interleukin 1 Interleukin 6 Interleukin-6 - genetics Interleukin-6 - metabolism Leukocyte migration Ligands Male MAP Kinase Kinase Kinases - metabolism MAP Kinase Signaling System Microvasculature Middle Aged Models, Biological Monocytes Neurobiology Neurology Neuropathogenesis Neurosciences Phosphorylation RNA, Double-Stranded - metabolism RNA, Messenger - genetics RNA, Messenger - metabolism Serine Stat1 protein TAK1 protein TLR3 protein Toll-Like Receptor 3 - genetics Toll-Like Receptor 3 - metabolism Toll-like receptors Transcription activation Transcription factors Transcription, Genetic Up-Regulation - genetics |
SummonAdditionalLinks | – databaseName: Health & Medical Collection (Proquest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Pb9MwFLZgXLggYPwIDPSQEAdQpCR2Y4cLKqhTt7GJQzf1Fjl-zojWuYW0wP4i_k383LSlTOzSS9LW1rOfv_fD38fYa5P06pxUA2RtsljQh85VHhe17enKoixCTvf4JB-eisNxb9wl3NqurXLlE4OjxqmhHLkP0nskjCuV-DD7FpNqFFVXOwmN2-wOUZdRS5ccbwIuH84smT4LP5ZcqFVVM1ydy4iskXw0SU_EavtcugY2r_dM_lM4DefR_n12rwOS0F9a_gG7Zd1Dttt3Poi-vII3EFo7Q858l_0eeWvHn5sLCx4m2pmPs2MOx0Glw7YwPDjzIR6JeBiLEHKEE7u4aFycw-BX1ynroHHg0SKEtD98JGkJGDikG1yTZnEJPxoNo_5RCtohHJ4cwRcPLn_qq_Y9HPzVtg4eJcNZ4ycHgRiEJJGn5-Rxm_YRO90fjD4N406hITai4PMYbVoXoqJaYiItR6wyrURaGZQWRSULg1WqNObccOTaZmiw5rwwdWKUVBV_zHbc1NmnDFSC_jhF_1MohE4rxem-tEEtOCY1VhFLVvYpTUdfTioak3JDvEwmLb1JSzJpqSL2dv2V2ZK746aX91ZGL7tt3JabRRexV-vHfgNSVUU7O120JbkwIT3w5RF7slwj63_LipQKuXnE5NbqWb9A5N7bT1zzNZB85x4XZ9IP691qnW2G9d9JPLt5Es_ZXY_31LLbeI_tzL8v7AuPqebVy7Bx_gAn9R_J priority: 102 providerName: ProQuest |
Title | Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis |
URI | https://link.springer.com/article/10.1007/s12035-017-0816-8 https://www.ncbi.nlm.nih.gov/pubmed/29128906 https://www.proquest.com/docview/2052883784 https://www.proquest.com/docview/1963475403 https://pubmed.ncbi.nlm.nih.gov/PMC6226278 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbY9sILAsalMKqDhHgARUpiN3Z4a1FLt7JqQu1UniLHdiBa506kBfaL-Jscu0lLGSDxEj_EcWwdX75z8fkIeaHCTpE41gBeqDhg7iETkQRpYToyN5qn3qZ7Ok6GU3Yy68zqe9xVE-3euCT9Tr297Ba79IpuV3VkEYHYIwcdp7rjJJ7G3Y2WhTrMOr1nih1ImGhcmX9qYvcwuoEwbwZK_uYt9YfQ4C65U6NH6K7FfY_cMvY-Oexa1Jwvr-El-HhObyg_JD8mKOLgfXlhALGhuULlOqBw6qk5TAXD43PU6xxzhzIavGFwblYXpQ0S6H-vw2MtlBYQIoK39UPP8UlA32p3bWteri7haylh0h1FIK2Gk_EIzhBRfpPX1Rs4_iVWHRAaw3mJgwOfDcTxIC8-uW22rB6Q6aA_eTsMalqGQLGULgNtoiJluXMghtxQrfNYChblSnOjWc5TpfNISJ1QRTWVJtZKF5SmqgiV4CKnD8m-XVjzmIAINZ6hGpvSjMkoF9RdklZaMqrDQuctEjbyyVSds9xRZ8yzbbZlJ9IMRZo5kWaiRV5tPrlaJ-z4V-WjRuhZvXarLA47joKZC9YizzevcdU5V4q0ZrGqMrdvMY5ol7bIo_Uc2fwtTiPnvU1ahO_Mnk0Fl9F7940tP_vM3gmC4Zhjt14382zbrb8O4sl_1X5KbiPmE-uI4yOyv_yyMs8QVy3zNtnjM94mB91Brzd25buPoz6Wvf747EPbr7KfO4Mhzw |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXBJRHoMAgAQeQJdu7sddICKWQKmkeqlBa9ebau2uwmjoBJ5T8Im78Rmb8SAgVvfXiy_o1mtnZb3Zm52PspbJbiUesAX6iXEvQJfKkZwWJaUWx0X5Q7OkOR173SByctE622O_6LAyVVdY-sXDUeqpojxyD9BYR4_pSfJh9s4g1irKrNYVGaRZ9s7zAkC1_3_uE-n3luvud8ceuVbEKWEoEfG5p4ySBiCn_ZfuGax27kRROrLRvtIj9QOnYkZH2uOKaR8bVSiecByqxlfRlzPG9N9i24Chig23vdUaHn1chHgZQZW_RAKX3hKzzqMVhPZfaQ9KqQGQXltxcCS_B28tVmv-kaosVcP8Ou11BV2iXtnaXbZnsHttpZxi2ny_hNRTFpMUu_Q77NUb7sgbpmQEEpmaGkb3FYVjwgpgcur1jDCqJNkQZDcWu5MQsztLM8qDzs6rNzSDNAPEpFIkG2CMyC-hkms6MTdLFOfxIIxi3-w5EmYaDUR8OEc5eRMv8HfT-KpQHxOVwnKJwULQiIRLm6Rfy8Wl-nx1di_YesEY2zcwjBtLWuIBrfJUWInJiyemEttKR4NpOdNxkdq2fUFUN04m3YxKuWz2TSkNUaUgqDWWTvVk9Miu7hVx1826t9LByHHm4NvMme7EaxilPeZwoM9NFHpLTFD5Cbd5kD0sbWX3NDRxKHXtN5m9Yz-oGaie-OZKlX4u24h4icdfH33pb29n6t_4rxOOrhXjObnbHw0E46I36T9gtRJuyrHXeZY3594V5iohuHj-rphGw0-ueuX8AaCJgzg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIiEuCCiPQIFBAg4gC9vreNdICAWaKGnaqIe0ys3Yu2uwmjoBJ5T8Iv4Dv46ZdZwQKnrrxRc_1_PYb3Zm52PshXKbWUisASJTvhPQIQll6ESZaSap0SKya7qHg7B7HOyPmqMt9rveC0NllbVPtI5aTxStkWOQ3iRiXCGDt9myLOJor_Nh-s0hBinKtNZ0GpWK9M3iHMO38n1vD2X90vc77eGnrrNkGHBUEPGZo42XRUFKuTBXGK516icy8FKlhdFBKiKlU08mOuSKa54YXyudcR6pzFVSyJTjc6-x64I3PbIxMVoHexhKVV1GI_wPYSDrjKrdtudTo0iaH4j2wpGbc-IFoHuxXvOfpK2dCzu32a0liIVWpXV32JYp7rKdVoEB_NkCXoEtK7Xr9Tvs1xA1zTnITw0gRDVTjPEdDoeWIcSU0O2dYHhJBCLKaLDrk2MzP80LJ4T2z2WVbgF5AYhUwaYc4CPRWkC70LR7bJzPz-BHnsCw1fcgKTTsD_pwhMD2PFmU76D3V8k8IEKHkxwHB7YpCdExT76Qt8_Le-z4SmR3n20Xk8I8ZCBdjVO5xkfpIEi8VHLaq610EnDtZjptMLeWT6yWrdOJwWMcr5s-k0hjFGlMIo1lg71e3TKt-oZcdvFuLfR46ULKeK3wDfZ8dRqNnzI6SWEm8zIm9xkIBN28wR5UOrJ6mx95lEQOG0xsaM_qAmosvnmmyL_aBuMhYnJf4Ge9qfVs_Vn_HcSjywfxjN1Ae40PeoP-Y3YTYaesip532fbs-9w8QWg3S59aGwL2-aqN9g_FnWOe |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toll-Like+Receptor-3+Mediates+HIV-1-Induced+Interleukin-6+Expression+in+the+Human+Brain+Endothelium+via+TAK1+and+JNK+Pathways%3A+Implications+for+Viral+Neuropathogenesis&rft.jtitle=Molecular+neurobiology&rft.au=Bhargavan%2C+Biju&rft.au=Kanmogne%2C+Georgette+D&rft.date=2018-07-01&rft.eissn=1559-1182&rft.volume=55&rft.issue=7&rft.spage=5976&rft_id=info:doi/10.1007%2Fs12035-017-0816-8&rft_id=info%3Apmid%2F29128906&rft.externalDocID=29128906 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-7648&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-7648&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-7648&client=summon |